Biopharmaceutical Co. Avacta Raises £10M To Support R&D
Avacta Group PLC said Friday it has conditionally raised £10 million ($13.3 million), which the biopharmaceutical company said it plans to use for its research and development programs....To view the full article, register now.
Already a subscriber? Click here to view full article